KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Tax Provisions (2016 - 2026)

Cme has reported Tax Provisions over the past 18 years, most recently at $356.6 million for Q1 2026.

  • Quarterly Tax Provisions rose 23.56% to $356.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Mar 2026, up 26.8% year-over-year, with the annual reading at $1.3 billion for FY2025, 23.9% up from the prior year.
  • Tax Provisions was $356.6 million for Q1 2026 at Cme, down from $395.5 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $395.5 million in Q4 2025 and troughed at $189.4 million in Q4 2022.
  • The 5-year median for Tax Provisions is $258.2 million (2024), against an average of $256.3 million.
  • Biggest five-year swings in Tax Provisions: fell 5.46% in 2024 and later soared 78.15% in 2025.
  • Tracing CME's Tax Provisions over 5 years: stood at $189.4 million in 2022, then increased by 1.06% to $191.4 million in 2023, then increased by 15.99% to $222.0 million in 2024, then skyrocketed by 78.15% to $395.5 million in 2025, then dropped by 9.84% to $356.6 million in 2026.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $356.6 million, $395.5 million, and $269.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.